ANTIMIKROBIELLE PARENTERALE FORMULIERUNG

European patent · EP2185143 · In force

Register entry

Publication number
EP2185143
Application number
EP08797186
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Aug 5, 2008
Published
May 19, 2010
Granted
Jan 2, 2013
Protection ends at the latest
Aug 4, 2028
Next annual fee due
Aug 31, 2026
IPC classes
A61K 31/05 (2006.01)
A61K 31/19 (2006.01)
A61K 47/14 (2006.01)
A61K 31/4709 (2006.01)
A61P 31/00 (2006.01)
A61P 31/04 (2006.01)
Priority
US 836241 09.08.2007
PCT application
PCT/US2008/072210 05.08.2008
PCT publication
WO2009/023473 19.02.2009
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Sep 1, 2025

    Change

    Published in Swissreg on 01.09.2025

  2. Sep 1, 2024

    Change

    Published in Swissreg on 01.09.2024

  3. Sep 1, 2023

    Change

    Published in Swissreg on 01.09.2023

  4. Sep 7, 2022

    Change

    Published in Swissreg on 07.09.2022

  5. Jan 2, 2013

    Granted

    Published in Swissreg on 02.01.2013

Parties

Holder

Taigen Biotechnology Co., Ltd.

7F 138 Shin Ming Road Neihu District, Taipei 114, TW

Inventor

LEE, Lih-Huei

Sansia Township 237, TW

WU, Po-Yi

Banciao City 220, TW

SUN, Erkuan

Jiangsu, CN

KING, Chi-Hsin Richard

Holladay, Utah 84124, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.